Location History:
- College Station, TX (US) (2019)
- Waco, TX (US) (2020)
Company Filing History:
Years Active: 2019-2020
Title: Ken Hull: Innovator in Pharmaceutical Research
Introduction
Ken Hull is a notable inventor based in Waco, Texas. He has made significant contributions to the field of pharmaceutical research, particularly in the development of treatments for chronic lymphocytic leukemia. With a total of two patents to his name, Hull's work is recognized for its innovative approach to cancer treatment.
Latest Patents
Ken Hull's latest patents include "Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia" and "Pateamine A derivatives and pharmaceutical compositions that include the derivatives." These patents focus on the development of pateamine A derivatives that are α-amino compounds lacking the C5-methyl group of pateamine A. This innovative approach aims to enhance the efficacy of treatments for chronic lymphocytic leukemia.
Career Highlights
Hull is affiliated with the Texas A&M University System, where he conducts his research and development work. His contributions to the field have been instrumental in advancing the understanding and treatment of chronic lymphocytic leukemia.
Collaborations
Some of Ken Hull's notable coworkers include Daniel Romo and Mingzhao Zhu. Their collaborative efforts have further enriched the research environment and fostered innovation in their projects.
Conclusion
Ken Hull's work exemplifies the spirit of innovation in pharmaceutical research. His patents and collaborations contribute significantly to the ongoing fight against chronic lymphocytic leukemia.